Novogen (NVGN)

Add to Watchlists Create an Alert
3.264 -0.10  -2.86% NASDAQ Sep 15, 8:00PM BATS Real time Currency in USD
View Full Chart
NVGN Price Chart
View All Events

NVGN Events

Date Type Description
11/15/2013 Misc AGM Event for Novogen Limited
View All Performance Charts

NVGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Novogen is down 14.11% over the last year vs S&P 500 Total Return up 20.89%, AstraZeneca up 51.49%, and Bristol-Myers Squibb up 20.83%.

Get Quote for

Portfolio Strategies Featuring NVGN

Did Novogen make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NVGN Profile

Novogen Ltd is engaged in pharmaceutical drug development. It develops single drug capable of killing both the dominant differentiated cells in a cancer as well as the undifferentiated cancer stem cells at a therapeutic dose.

NVGN Excel Add-In Codes

  • Name: =YCI("NVGN","name")
  • Description: =YCI("NVGN","description")
  • Sector: =YCI("NVGN","sector")
  • Industry: =YCI("NVGN","industry")
  • Est. Current Fiscal Year End: =YCI("NVGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start your {{}} Membership


{{ ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{}} Member? Sign in here.